Home › Funds › BOSTON RESEARCH & MANAGEMENT INC › MDT
BOSTON RESEARCH & MANAGEMENT INC position in MDT
MEDTRONIC PLC · Health Care
BOSTON RESEARCH & MANAGEMENT INC reported holding 51,651 shares of MDT (MEDTRONIC PLC) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 0.98% of its reported portfolio and ranking #46 among its reported holdings. BOSTON RESEARCH & MANAGEMENT INC has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BOSTON RESEARCH & MANAGEMENT INC's MDT position evolved
BOSTON RESEARCH & MANAGEMENT INC first disclosed a stake in MDT in Q3 2023 at 53,515 shares (US$4.2M). The position peaked in Q3 2025 at 50,779 shares, worth US$4.8M. Across 13 filings, BOSTON RESEARCH & MANAGEMENT INC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 51,651 shares valued at US$4.5M — an increase of 450 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 53.52K | $4.19M | New |
| Q4 2023 | 47.10K | $3.88M | Reduce |
| Q1 2024 | 47.90K | $4.17M | Add |
| Q2 2024 | 48.49K | $3.82M | Add |
| Q3 2024 | 51.31K | $4.62M | Add |
| Q4 2024 | 51.22K | $4.09M | Hold |
| Q1 2025 | 48.85K | $4.39M | Reduce |
| Q2 2025 | 50.63K | $4.41M | Add |
| Q3 2025 | 50.78K | $4.84M | Hold |
| Q4 2025 | 49.04K | $4.71M | Reduce |
| Q1 2026 | 50.55K | $4.38M | Add |
| Q2 2026 | 51.20K | $4.01M | Add |
| Q3 2026 | 51.65K | $4.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDT and 13F data
MDT (MEDTRONIC PLC) is a Health Care company. 20 other funds we track also report a position in MDT — the largest reported positions include MFS Investment Management (US$2.56B), Deutsche Bank AG (US$1.55B), First Eagle Investment Management (US$1.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDT
- MFS Investment Management 18.09M sh · $2.56B · Q3 2026
- Deutsche Bank AG 18.00M sh · $1.55B · Q3 2026
- First Eagle Investment Management 13.95M sh · $1.20B · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 12.23M sh · $1.06B · Q3 2026
- Arrowstreet Capital 12.89M sh · $1.01B · Q2 2026
More on BOSTON RESEARCH & MANAGEMENT INC
FAQ
How long has BOSTON RESEARCH & MANAGEMENT INC held MDT?
BOSTON RESEARCH & MANAGEMENT INC has disclosed MDT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BOSTON RESEARCH & MANAGEMENT INC's current position in MDT?
As of Q3 2026, BOSTON RESEARCH & MANAGEMENT INC holds 51.65K shares of MDT (MEDTRONIC PLC), valued at $4.46M, representing 0.98% of its reported portfolio and ranking #46.
Has BOSTON RESEARCH & MANAGEMENT INC been buying or selling MDT?
In the latest 13F filing (Q3 2026), BOSTON RESEARCH & MANAGEMENT INC increased its position in MDT. The position peaked in Q3 2025 at 50.78K shares.
Which other funds hold MDT?
Other major institutional holders of MDT include MFS Investment Management, Deutsche Bank AG, First Eagle Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.